Estée Lauder
Up to $5,000
Claims opening soon
Consumers and entities who purchased QVAR or QVAR Redihaler between January 1, 2015, and July 31, 2025, may be eligible for a share of this $35 million antitrust settlement.
Allegations that Teva engaged in antitrust practices to prevent generic competition for its QVAR asthma medication.
Teva Pharmaceuticals has agreed to a $35 million settlement to resolve claims of antitrust behavior related to its QVAR asthma medication. The settlement benefits individuals and entities who purchased or reimbursed QVAR or QVAR Redihaler within a specified period and in eligible states.
You may be eligible if you:
Proof details
Documentation such as receipts, invoices, pharmacy statements, or insurance statements with explanations of benefits may be required.
If you do not have every document, you may still be able to file. Many settlements accept claims without receipts.
Most claims can be completed in 10-12 minutes.
Documentation such as receipts, invoices, pharmacy statements, or insurance statements with explanations of benefits may be required.
The current claim deadline is July 31, 2026.
Varies
Claim deadline: July 31, 2026
Estée Lauder
Up to $5,000
Claims opening soon
Silk and Great Value
Up to $300,000
93 days left
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
743 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon